Talis Biomedical Corporation TLIS

2.84 0.00 0.00% as of 1 Apr
Market cap
$46.3M
P/E
0.0×
Growth Flags show if company had growth for consecutive years

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Older periods Sep '23 Dec '23 Mar '24 Jun '24
Cash and Short Term Investments

+8 more quarters

88.00 76.73 70.34 59.87
Receivables
0.01 0.05 0.01 —
Other current assets
1.53 — — —
Total current assets
89.53 77.68 71.17 63.60
Property, Plant, Equpment (Net)
3.33 3.03 1.63 0.43
Long-term assets (Other)
1.54 1.54 1.54 0.77
Total non-current assets
17.70 16.99 11.32 9.10
Total Assets
107.23 94.67 82.49 72.70
Accounts Payable
2.70 1.34 3.62 3.79
Accrued Expenses
2.89 4.55 2.95 1.48
Total current liabilities
8.45 8.77 9.47 8.20
Total non-current liabilities
17.22 16.79 16.34 15.88
Total liabilities
25.67 25.56 25.81 24.07
Additional Paid In Capital
608.05 609.07 609.68 610.47
Preferred Stock (Total)
0.00 0.00 0.00 0.00
Retained Earnings
(526.50) (539.96) (553.00) (561.84)
Common Equity (Total)
81.55 69.11 56.68 48.62
Shareholders Equity (Total)
81.56 69.12 56.68 48.63
Shareholders Equity and Liabilities (Total)
107.23 94.67 82.49 72.70
Shares (Common)
1.82 1.82 1.82 1.82
Shares (Preferred)
29.86 29.86 29.86 29.86
Shareholders Equity (Tangible)
81.56 69.12 56.68 48.63
Net Debt
(88.00) (76.73) (70.34) (59.87)
Total Debt
20.08 — — —

Fold the line items

In millions of $ except per-share values · columns are period end dates